Rituximab biosimilar, premium grade, Unconjugated, Human

Produktübersicht

• Artikelname: Rituximab biosimilar, premium grade, Unconjugated, Human
• Artikelnummer: ABS-CD0-M36A2-100UG
• Hersteller Artikelnummer: CD0-M36A2-100ug
• Alternativnummer: ABS-CD0-M36A2-100UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Mouse
• Konjugation: Unconjugated

Produktbeschreibung

Rituximab biosimilar, premium grade (CD0M36A2) is a chimeric monoclonal antibody recombinantly produced from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. - Antikörper

Produkteigenschaften

• Tag: Human IgG1 | Human Kappa
• Puffer: 25 mM Sodium citrate, 150 mM NaCl, pH6.5
• Reinheit: 0.95
• Formulierung: Liquid
• Target-Kategorie: CD20

Bilder

Immobilized Biotinylated Human CD20 Full Length, His,Avitag (Cat. No. CD0-H82E5) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Rituximab biosimilar, premium grade (Cat. No. CD0-M36A2) with a linear range of 0.031-1 µg/mL (QC tested).

Immobilized Human CD20 Full Length Protein-VLP (Cat. No. CDP-H52P6) at 5 µg/mL (100 µL/well) can bind Rituximab biosimilar, premium grade (Cat. No. CD0-M36A2) with a linear range of 0.016-1 µg/mL (Routinely tested).

Rituximab biosimilar, premium grade on SDS-PAGE under reducing (R) and under non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.